Comments
Loading...
Kura Oncology (NASDAQ:KURA) Stock Quotes, Forecast and News Summary
Kura Oncology Stock (NASDAQ: KURA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kura Oncology (KURA) stock?
You can purchase shares of Kura Oncology (NASDAQ:KURA) through any online brokerage.
Who are Kura Oncology (KURA) competitors?
Other companies in Kura Oncology’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB) and Cogent Biosciences (NASDAQ:COGT).
What is the forecast, or price target, for Kura Oncology (KURA) stock?
Kura Oncology has a consensus price target of $28.21.
What is the current price for Kura Oncology (KURA)?
The stock price for Kura Oncology (NASDAQ: KURA) is $11.85 last updated November 21, 2024 at 9:30 AM EST.
Does Kura Oncology (KURA) pay a dividend?
There are no upcoming dividends for Kura Oncology.
When is Kura Oncology (NASDAQ:KURA) reporting earnings?
Kura Oncology’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Kura Oncology (KURA) going to split?
There is no upcoming split for Kura Oncology.
What sector and industry does Kura Oncology (KURA) operate in?
Kura Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.